Project cooperationUpdated on 17 February 2025

Policapr – The Future of Personalized Medication Delivery

Ayhan Olcay

CEO at Innoway R&D Kft.

Budapest, Hungary

About

🚀 Executive Summary: Policapr – The Future of Personalized Medication Delivery

Problem & Market Need

Medication non-adherence leads to poor health outcomes, increased hospitalizations, and $500B in preventable healthcare costs. Patients with chronic diseases like cardiovascular conditions struggle to manage complex drug regimens, leading to missed doses, treatment failure, and reduced efficacy.

Solution: Policapr

Policapr combines multiple prescriptions into a single, personalized polypill using polymer-based drug release and automated compounding technology. This simplifies medication management, enhances adherence, and improves patient outcomes, offering a scalable, cost-effective, and transformative drug delivery solution.

Key Differentiation & Competitive Advantage

✅ Personalized, controlled drug release vs. traditional pill sorting

✅ Automated compounding for precision dosing and scalability

✅ Licensable technology for pharma integration and commercialization

✅ More cost-effective and scalable than 3D-printed medications or manual compounding

Similar opportunities